SPRIG Equity is a growth equity and late-stage venture capital firm focused on medical technology innovation. The firm invests in medical devices, diagnostics, and tech-enabled healthcare services, partnering with companies addressing unmet needs in the healthcare system. SPRIG Equity operates as an extension of SPRIG Consulting, a MedTech strategy and marketing consulting firm, leveraging proprietary deal flow and sector expertise. The firm's portfolio includes notable exits such as Affera (acquired by Medtronic), BridgePoint Medical (acquired by Boston Scientific), NeuroPace (NASDAQ: NPCE), Valeritas (NASDAQ: VLRX), and Vertos Medical (acquired by Stryker). The principals collectively have over 70 years of healthcare experience and have participated in 16 investment exits through IPO or M&A across their careers.
Profile auto-generated from public sources — details unverified.